TELA Bio (TELA) Gross Margin (QoQ) (2018 - 2026)

TELA Bio (TELA) Gross Margin (QoQ) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 181.32 Bn 174.03 Bn 6.27 Bn
2 Stryker 128.59 Bn 125.71 Bn 3.81 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn
4 Boston Scientific 67.77 Bn 66.32 Bn 3.61 Bn
5 Edwards Lifesciences 48.13 Bn 44.46 Bn 1.29 Bn
6 GE HealthCare Technologies 28.44 Bn 26.15 Bn 1.98 Bn
7 Dexcom 28.41 Bn 27.29 Bn 750.30 Mn
8 Smith & Nephew 26.77 Bn 26.20 Bn -
9 Koninklijke Philips 25.24 Bn 22.11 Bn 2.07 Bn
10 TELA Bio 35.02 Mn -4.52 Mn 12.52 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -22.00
Dec 31, 2025 -161.00
Sep 30, 2025 -232.00
Jun 30, 2025 228.00
Mar 31, 2025 398.00
Dec 31, 2024 -425.00
Sep 30, 2024 -99.00
Jun 30, 2024 54.00
Mar 31, 2024 -11.00
Dec 31, 2023 -64.00
Sep 30, 2023 -136.00
Jun 30, 2023 406.00
Mar 31, 2023 -403.00
Dec 31, 2022 476.00
Sep 30, 2022 264.00
Jun 30, 2022 221.00
Mar 31, 2022 -684.00
Dec 31, 2021 745.00
Sep 30, 2021 -718.00
Jun 30, 2021 835.00